-transparent.png){kind=logo}
The prevalence of lupus anticoagulant (LAC) and its relation with reported clinical associations has been determined in 55 patients with systemic lupus erythematosus (SLE) from northern India who were studied prospectively. Kaolin clotting time was used to screen for LAC, which was detected in seven (13%) of the patients. Significant associations were found between LAC and thrombotic events, onset of disease at an early age, and disease of shorter duration. No statistically significant association could be found between LAC and recurrent abortions, pulmonary hypertension, thrombocytopenia, and neurological manifestations. It is concluded that LAC is a useful marker for a subset of patients with SLE at risk of thromboembolic events.
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
May 1991,
Revista medica de Chile,
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
January 1987,
Scandinavian journal of rheumatology,
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
November 2023,
Rheumatology (Oxford, England),
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
July 1983,
Medicina clinica,
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
November 2000,
Rheumatology (Oxford, England),
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
February 1996,
Ryumachi. [Rheumatism],
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
July 2005,
Pathologie-biologie,
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
September 1991,
Clinical rheumatology,
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
January 2008,
Immunological investigations,
K Padmakumar, and
R R Singh, and
R Rai, and
A N Malaviya, and
A K Saraya
July 2007,
The American journal of medicine,
